期刊文献+

化学热力学与生命科学 被引量:1

下载PDF
导出
摘要 综述了热力学中熵和自由能这两个重要状态函数在生命现象、肿瘤形成、抗癌药物研究、生物大分子结构研究、药物设计、蛋白质工程和基因优化表达等中的应用。
出处 《数理医药学杂志》 2007年第1期70-72,共3页 Journal of Mathematical Medicine
  • 相关文献

参考文献15

二级参考文献84

  • 1高盘良.现代熵理论与《物理化学》教学[J].大学化学,1994,9(2):21-23. 被引量:7
  • 2沈雪松.热力学与生命现象研究(综述)[J].广西科学,1994,1(4):59-60. 被引量:2
  • 3李伍举,吴加金.基于一级螺旋区的RNA二级结构绘图与自由能计算[J].军事医学科学院院刊,1995,19(4):293-296. 被引量:2
  • 4Baselga J, Yano K, Giaccone G, et al. Initial results from a phase trial of ZD 1839(Iressa) as second- and third-line monotherapy for patients with advanced nonsmall cell lung cancer (IDEAL 1 ). Clin Cancer Res,2001,7 (Suppl): 3780S.
  • 5Khuri FR, Rigas JR, Figlin RA, et al.Multi-institutional phase Ⅰ / Ⅱ trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer. J Clin Oncol,2001,19(10) : 2626-2637.
  • 6Hidalgo M, Siu LL, Nemunaitis J, et al.Phase Ⅰ and pharmacologic study of OSI774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies. J Clin Oncol,2001,19(13): 3267-3279.
  • 7Swisher SG, Roth JA, Komaki R, et al. A phase Ⅱ trial of adenoviral mediated p53gene transfer (RPR/INGN 201) in conjunction with radiation therapy in patients with localized non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol,2000,19 : 461a.
  • 8Kris MG, Herbst R, Rischin D, et al. Objective regressions in non-small cell lung cancer patients treated in phase Ⅰ trails of oral ZD 1839 (lressa), a selective tyrosine kinase inhibitor that blocks the epidermal growth factor receptor (EGFR). Lung Canc
  • 9AwadaA, Gil T, De Valeriola D, et al. A Phase Ⅰ , clinical and pharmacokinetic trial of Zarnestra (farnesyl transferase inhibitor, R115777) and docetaxel: A promising combination in patients with solid tumors.Clin Cancer Res,2001,7 (Suppl): 3774S.
  • 10Sharma S, Kemeny N, Kelsen DP, et al.A phase Ⅱ trial of farnesyl protein transferase inhibitor SCH 66336, given by twicedaily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan. Ann Oncol,2002,1

共引文献44

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部